IN8bio, Inc. (INAB)
NASDAQ: INAB · Real-Time Price · USD
0.1250
-0.0037 (-2.87%)
At close: May 19, 2025, 4:00 PM
0.1230
-0.0020 (-1.60%)
Pre-market: May 20, 2025, 8:47 AM EDT
IN8bio Market Cap
IN8bio has a market cap or net worth of $11.35 million as of May 20, 2025. Its market cap has decreased by -74.73% in one year.
Market Cap
11.35M
Enterprise Value
3.73M
1-Year Change
-74.73%
Ranking
Category
Stock Price
$0.13
Market Cap Chart
Since the IPO on July 30, 2021, IN8bio's market cap has decreased from $187.55M to $11.35M, a decrease of -93.95%. That is a compound annual growth rate of -52.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 19, 2025 | 11.35M | -39.14% |
| Dec 31, 2024 | 18.64M | -68.76% |
| Dec 29, 2023 | 59.67M | 5.43% |
| Dec 30, 2022 | 56.60M | -31.25% |
| Dec 31, 2021 | 82.33M | -56.10% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 677.89B |
| Johnson & Johnson | 366.90B |
| AbbVie | 328.04B |
| Novo Nordisk | 293.82B |
| UnitedHealth Group | 286.56B |
| Abbott Laboratories | 235.83B |
| Novartis AG | 215.48B |
| AstraZeneca | 214.95B |